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 Time-to-reperfusion, electrocardiographic and angiographic
parameters are of prognostic relevance in ST-elevation myocardial infarction
(STEMI) patients. We sought to evaluate predictors of Infarct size (IS) and
presence of microvascular obstruction (MO) using delayed hyper-enhance-




 We analyzed 128 consecutive STEMI patients reper-
fused by primary PCI within 12 hours after symptom onset. IS and MO were
assessed by delayed hyper-enhancement MRI as percentage of LV mass, 4±2 days
after acute MI. Reperfusion times, TIMI-flow grades pre and post PCI, 90 min ST-
segment resolution, cardiovascular risk factors, Killip-class, and infarct location
were assessed. In patients with TIMI flow 0-1 before PCI, IS was significantly
higher compared to patients with TIMI-flow 2-3 (22±12% versus 16±15%;
p<0.01). Similarly, the extent of MO occurrence was affected by the pre PCI TIMI
flow. A trend toward higher final IS and MO was noted in post PCI TIMI flow.
Patients with TIMI flow 0 to <3 IS was 28±11% versus 20±12% in TIMI-flow =3
(p=0.067). The ST-segment resolution correlated inversely with final IS and pres-
ence of MO (IS r=-0.34, p<0.01; MO r=-0.31, p<0.01). IS was significantly higher
in anterior AMI versus inferior AMI (24±16% versus 17±12%; p<0.01 as well as
MO (9.8±7.8%vs. MO 4.8±3.7%; p=0.01). In a multivariable model the strongest
predictors of IS and MO were pre-PCI TIMI-flow, infarct location, admission




 The pre-PCI TIMI flow, infarct location, Killip class and ST-
segment resolution are the strongest predictors of IS and extent of MO as
assed by delayed Hyper-enhancement MRI. CMR allow for strong evaluation
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sPLA2 and Lp-PLA2 are currently being evaluated as potential markers and
therapeutic targets in coronary artery disease. We hypothesized that their mea-
surement, in parallel with CRP, could correlate to the risk of death or myocardial
infarction (MI) in patients with suspected acute coronary syndromes (ACS), pro-
viding thereby important prognostic information. We therefore analysed a cohort
of 419 unselected consecutive patients (mean 61.1 years old ; 63.9 % male) pre-
senting in the emergency room of a large tertiary hospital, without ST-segment
elevation (NSTE) on the baseline ECG, with chest pain (72 %) or other clinical
features considered indicative of ACS. Clinical history, basal troponin I (cTnI)
and CRP measurements were obtained. Final discharge diagnoses were assigned
to the following categories: NSTE-ACS including NSTE-MI and unstable angina
(UA), other cardiac diseases (OCD) or non cardiac diseases (NCD). Follow-up
was obtained in all patients at 40 days. sPLA2 mass, sPLA2 and Lp-PLA2 activ-
ities were measured on the serum samples collected at presentation. The median
sPLA2 activity was significantly higher in NSTE-ACS patients (1.89), than in
OCP and NCP patients (1.45 and 1.43 respectively; p< 0.001). A significant asso-
ciation between sPLA2 mass and diagnosis (p<0.02) was also found, while the
Lp-PLA2 activity appeared not to be associated with the final diagnosis. Patients
with sPLA2 activity or mass at presentation in the highest quartile had a statisti-
cally higher incidence of cardiac death and MI than those with sPLA2 activity or
mass in the lowest quartile (37.5% versus 13.4 %, p=0.0001 and 33.6% versus
16%; p=0.0047, respectively). On the other hand, no association was observed
with Lp-PLA2 activity. Therefore, a single measurement of sPLA2 activity in
 
unselected patients presenting with suspected ACS and no ST-segment elevation,
provides better independent prognostic information than either CRP, sPLA2 mass
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 Erythrocytes transfusion is an independent risk factor for
recurrent ischemic events and mortality in patients suffering from acute coro-





 We hypothesized that red blood cell transfusion would activate
platelet aggregation and we sought to identify which are the pathway involved




 Healthy volunteers (n=15) provided blood samples that were
mixed with red blood cell (tRBC) obtained from transfusion packs. We
explored platelet activation using light transmission agregometry with four dif-
ferent agonist (ADP, Arachidonic Acid (AA), Collagen and Epinephrin) in 10
volunteers and with flow cytometry for P-selectin and VASP in 5 volunteers.
Measures were obtained at baseline (whole blood from healthy volunteers),
after in vitro transfusion with a 1:4 ratio of tRBC and after in vitro transfusion
with a 1:4 ratio of tRBC and hematocrit adjustement with platelet poor plasma.




 Theses are preliminary results from the ongoing TRANSFUSION
study. Numerical values are given in table 1. 1/ RBC transfusion activates
platelet aggregation thought ADP and AA pathway. 2/ This effect was con-
firmed by increase in P-Selectin platelet content with flow cytometry and is
independent of an increase in hematocrit. 3/ P2Y12 activation pathways is




 Red Blood Cell transfusion activates platelet thought ADP
and AA pathway in healthy volunteers. This may explain the independent
association between transfusion and recurrent ischemic events including mor-
tality in ACS patients.
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 In patients admitted with acute coronary syndromes (ACS),
those with anemia are at higher risk. However, current risk score systems do
not take into account the presence of anemia.
 
n=10 n=5
Technique Aggregometry (Residual 
Platelet Aggregation %)
P-Selection % PRI 
(%)
 














Baseline 58,0 79,5 61,6 65,0 33,6 40,2 68,4
After tRBC 
(no adjustement)




p value 0,03*0,04* 0,13 0,15 ND ND ND
 
(*<0,05; ND=not done)
